WASHINGTON--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP), unveiled the new name and new industrial design for its non-invasive and painless test for the early detection of cervical precancer. LuViva™ will be on display at The American College of Obstetricians and Gynecologists (ACOG) Clinical Meeting in Washington, D.C. through May 4, 2011 in Washington, D.C.